Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Cash from Financing Activities (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Cash from Financing Activities data on record, last reported at $15.1 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 455.96% year-over-year to $15.1 million; the TTM value through Sep 2025 reached $97.5 million, up 10.27%, while the annual FY2024 figure was $70.6 million, 115.77% up from the prior year.
  • Cash from Financing Activities reached $15.1 million in Q3 2025 per FBIO's latest filing, up from $4.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $78.7 million in Q1 2021 and bottomed at -$30.4 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is $21.0 million, with a median of $18.6 million recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: crashed 1115.75% in 2023, then surged 455.96% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $38.9 million in 2021, then crashed by 52.19% to $18.6 million in 2022, then soared by 134.28% to $43.6 million in 2023, then tumbled by 40.84% to $25.8 million in 2024, then plummeted by 41.59% to $15.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $15.1 million in Q3 2025, $4.5 million in Q2 2025, and $52.1 million in Q1 2025.